Apogee Therapeutics, Inc. Common Stock (APGE) stock news · $2.34B cap
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
This APGE news page leads with what Apogee Therapeutics, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for APGE yet. We will not pad this page with generic market recap.
APGE income-statement cache is thin, so the news desk waits on the next exhibit.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the APGE stock page; for the tape open the quote page.
APGE cached headlines
Newest cached · 2026-09-03T15:02:00.000Z
- ABBV Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell? — Yahoo Finance
- AbbVie Completes Acquisition of Apogee Therapeutics — Yahoo Finance
- Is AbbVie (ABBV) Undervalued As It Expands Skyrizi In Crohns Disease? — Yahoo Finance
- AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026? — Yahoo Finance
- AbbVie Defends Its Turf, But Leaves One Big Question Open — Yahoo Finance
- Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield — Yahoo Finance
+8 older cached headlines in the full archive.
These headlines as JSON? API free 100/dayAPGE stock news FAQ
What is APGE's latest news headline?
The latest cached Apogee Therapeutics, Inc. Common Stock (APGE) headline on this page is "ABBV Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?" from Yahoo Finance on Sep 3, 2026. Story: https://lician.com/news/apge/319. News: https://lician.com/news/apge
When was the latest cached APGE headline published?
The latest cached Apogee Therapeutics, Inc. Common Stock (APGE) headline on this page was published Sep 3, 2026. The earliest headline date on this page is Jul 31, 2026.
How many APGE headlines are listed on this page?
This page lists 14 cached Apogee Therapeutics, Inc. Common Stock (APGE) headlines. News: https://lician.com/news/apge
What other APGE headlines are listed on this page?
Other cached headlines on this Apogee Therapeutics, Inc. Common Stock (APGE) news page: "AbbVie Completes Acquisition of Apogee Therapeutics"; "Is AbbVie (ABBV) Undervalued As It Expands Skyrizi In Crohns Disease?"; "AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?". News: https://lician.com/news/apge
What source is listed on the APGE news page?
The cached source on this Apogee Therapeutics, Inc. Common Stock (APGE) news page is Yahoo Finance. News: https://lician.com/news/apge
What does the latest APGE headline say?
The latest cached Apogee Therapeutics, Inc. Common Stock (APGE) headline is "ABBV Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?". AbbVie's Skyrizi, Rinvoq and neuroscience drugs drive growth, but Humira erosion, oncology and Aesthetics remain key headwinds.
What is APGE's market cap?
Apogee Therapeutics, Inc. Common Stock (APGE) market cap is $2.34B on the latest cached fundamentals snapshot.
Where is APGE stock news listed?
Cached stock news for Apogee Therapeutics, Inc. Common Stock (APGE) is listed at https://lician.com/news/apge. Filings: https://lician.com/sec/apge
Not investment advice.